Abstract: Photocaging facilitates non-invasive and precise spatio-temporal control over the release of biologically relevant small-and macro-molecules using light. However,s ubcellular organelles are dispersed in cells in am anner that renders selective light-irradiation of ac omplete organelle impractical. Organelle-specific photocages could provide ap owerfulm ethod for releasing bioactive molecules in subcellular locations.H erein, we report ag eneral post-synthetic method for the chemical functionalization and further conjugation of meso-methyl BODIPY photocages and the synthesis of endoplasmic reticulum (ER)-, lysosome-, and mitochondria-targeted derivatives.W ea lso demonstrate that 2,4-dinitrophenol, am itochondrial uncoupler,a nd puromycin, ap rotein biosynthesis inhibitor,c an be selectively photoreleased in mitochondria and ER, respectively,i nl ive cells by using visible light. Additionally,p hotocaging is shown to lead to higher efficacy of the released molecules,probably owingto alocalized and abrupt release.
The interior of cells is ah ighly organized environment.
Cellular tasks such as energy production, protein synthesis, and many others,a re functionally compartmentalized in organelles,a long with most of the biomolecules required for their execution. Studying localized processes,including those taking place inside organelles,o ften makes use of smallmolecules to manipulate their progress. [1] Unfortunately,most small-molecules lack an innate specificity for cellular locations;they tend to disperse randomly in cells,not necessarily arriving at the desired place owing to unsuitable physicalchemical properties or conversely,e nding up in too many locations in an unspecific manner.
Photocaging [2] is an effective light-mediated controlledrelease strategy that enables activation of small-or macrobioactive molecules with high spatio-temporal resolution. [3] This strategy is widely utilized to achieve localized control over the activation of bioactive molecules in vitro and in vivo.
[4] However, organelles are scattered or dispersed in cells in am anner that renders selective irradiation of ac omplete organelle (e.g., mitochondria or golgi apparatus) impractical, undermining the utility of the strategy in this context. Over the years,s everal chemical motifs have been determined to passively accumulate in specific sub-cellular compartments owing to their chemical and/or physical properties (e.g., pH, charge,a nd hydrophobicity). Such motifs include,f or example,t riphenylphosphonium [5] (TPP), phenyl sulfonamide, [6] and tertiary/secondary amines [7] that tend to accumulate in mitochondria, endoplasmic reticulum (ER), and lysosomes/endosomes,respectively.Their coupling to small-and even macro-molecules was found to effectively impart sub-cellular specificity to the entire conjugate.
Thec ombination of sub-cellular targeting with photocaging,providing ameans of preserving the advantages of the two strategies while overcoming their distinct limitations,has been effectively demonstrated using 2-nitrobenzyl derivatives caging groups.
[8] However,t he use of UV-excitable photocages often leads to inherent hurdles,i ncluding sample overheating and phototoxicity.M ore recent work has effectively improved the utility of targeted photocages by using coumarins,excitable at around 400 nm, as caging groups.
[9]
Herein, we establish arange of organelle-targeted photocages based on the recently introduced, visible-light excitable (> 500 nm) meso-methyl BODIPY photocage [10] (Figure 1 ). Figure 1 . Schematic of ER-, lysosome-, and mitochondria-targeted BODIPY photocages.
To this end, we also developed as traightforward, postsynthetic method for the functionalization of BODIPYs that streamlines their synthesis. Thep hotoreaction efficiency in BODIPY photocages, [10d] as well as in many other photocaging groups, [11] is highly sensitive to changes in electronic and steric properties of the core.W etherefore first sought to establish arobust synthetic approach for chemical functionalization of BODIPY photocages without affecting their photorelease ability.
Thes ynthetic procedure is outlined in Figure 2A .U sing ao ne-pot, two-step protocol, that is,b romination with Nbromosuccinimide (NBS) followed by nucleophilic substitution, compounds 1-5 were synthesized. This is am odified approach to an earlier report, [12] which leverages the nucleophilic character of BODIPY a-methyls to introduce bromine as aleaving group.Inthis case,the superior nucleophilicity of thiols is employed to introduce less nucleophilic yet reactive functional groups through appropriate bifunctional molecules.T hus,v arious unprotected functional groups including amine,t hiol, chloro,c arboxylic acid, and azide groups,a ll key building blocks in the construction of more elaborate molecules,could be simply and directly introduced. We verified that the reactive functionalities installed can be further conjugated in the context of BODIPY photocages by reacting each of them in ac ompatible manner (i.e., amidation, Michael addition to N-ethyl maleimide,a nd coppermediated click reaction) (compounds 6-10,F igure S1).
Thep hotophysical and photoreaction properties of all synthesized compounds are summarized in Tables S1. Compared to previously reported BODIPY photocages, [10a,b,d] all new derivatives (1-10)p resent a5 -7 nm red-shift in both absorbance and fluorescence l max ,w ith molar extinction coefficient values in the typical BODIPY range (ca. 35 000-70 000 m À1 cm À1 ). Photoreaction properties were determined by UV/Vis spectroscopy,m onitoring p-nitroaniline (PNA) release (see Supporting Information). Compounds 5-8 and 10 are stable in the absence of light but release PNAinresponse to irradiation with visible light (545/30 nm, 42 mW cm À2 ), presenting comparable photoreaction properties (quantum yield (F r ), half-life (t 1/2 ), and chemical yield) to previously reported BODIPY photocages (Table S1, Figure S2 ). These results confirm that the above-described post-synthetic methodology can be straightforwardly applied to conjugate BODIPY photocages through diverse chemical functionalities while retaining their spectroscopic and photoreaction properties.
We next applied the synthetic approach to generate ap anel of organelle-targeted BODIPY photocages.Adirect HBTU-mediated coupling of compound 4 with different amine-bearing organelle-directing groups such as phenyl sulfonamide (ER targeting), morpholine (lysosome targeting), and TPP (mitochondria targeting), afforded targeted BODIPY photocages 11-13,r espectively ( Figure 2B ). Compounds 11-13 are stable in the absence of light and show controlled release of PNAupon irradiation with visible light (Table S1 and Figure S3 ). Their cellular uptake and subcellular localization were evaluated in HeLa cells by live-cell imaging using commercial stains for ER, lysosomes,a nd mitochondria (Figures 3a nd Figures S9 and S10 ). All three compounds demonstrated efficient localization to their target organelles as determined by Pearsonss ample correlation coefficients (r = 0.95, 0.73, and 0.75 for 11, 12,a nd 13, respectively) with the respective organelles stains (ERtracker Blue,L ysoTracker deep-red, and MitoTracker deepred).
To evaluate the utility of organelle-targeted BODIPY photocages,wesynthesized and tested acaged version of the protonophore 2,4-dinitrophenol (DNP). DNP is an uncoupler of mitochondrial oxidative phosphorylation, dissipating the proton gradient across the membrane thus decreasing mitochondrial membrane potential [13] (Dy m ). Compound 14 was synthesized by ipso-substitution of 1-fluoro-2,4-dinitroben- zene with meso-methyl BODIPY and functionalized by employing the above-described protocol using thioglycolic acid as anucleophile.ATPP motif was subsequently coupled to obtain the mitochondria-targeted BODIPY-DNP 16 (Figures 4A and Figure S4 ). Quantum yields,half-lives (t 1/2 ), and chemical yields for photorelease of DNP were determined by UV/Vis spectroscopy and confirmed by HPLC-MS.C ompounds 14 and 16 are stable in the dark and release DNP when irradiated with visible light (Figures 4B and Figures S5 and S6) , compound 16 presenting the highest photorelease efficiency (eF r = 43) within this series of compounds (Table S1 ). Although BODIPY photocages were previously demonstrated to release halides,a cids,c arbon monoxide, thiols,and xanthates, [10] this is first example of direct uncaging of phenols,e xpanding the palette of functional groups and bioactive molecules amenable for caging by BODIPYs.
Cellular uptake and mitochondrial localization of 16 were examined and compared to the non-targeted 14 by live-cell imaging of HeLa cells ( Figures 4C and Figures S9 and S11 ). Low Pearsonss ample correlation coefficients (r = 0.13) confirmed poor targeting of 14 to the mitochondria while 16 showed efficient and specific mitochondrial accumulation (r = 0.84).
Next, intracellular photoactivation of 16 was investigated. Changes in Dy m were assessed using the Dy m -sensitive lipophilic cationic dye,r hodamine 123 (Rho123). In intact cells,R ho123 accumulates in mitochondria, leading to as trong localized fluorescence signal. [14] Conversely,r eduction in Dy m leads to redistribution of the dye to the cytoplasm, resulting in its dilution and adecrease in fluorescence signal. In HeLa cells treated with Rho123, strong mitochondrial fluorescence could be detected, which was significantly reduced (ca. 3-fold) by further treatment with 200 mm DNP ( Figure 4D and Figure S12 ). When similar cells were treated with Rho123 and 16 (25 mm), am itochondria-localized fluorescence signal was observed, indicating that 16 by itself does not disrupt Dy m .However,upon irradiation of the cells (545/25 nm, 1.4 mW cm À2 ,1 5s), a6 -fold decrease in Rho123 mitochondrial fluorescence was observed. Importantly,p hotoactivation of the non-targeted 14 under similar conditions did not have any effect on Rho123 fluorescence.Cells treated with Rho123 alone and exposed to similar irradiation conditions did not show any change in mitochondrial fluorescence,ruling out direct light effect on Dy m .Inaddition, in the absence of light, 16 did not show any sign of toxicity at the applied concentration ( Figure S14) .
Finally,wetested light-mediated selective activation of 16 in specific cells.T hus,H eLa cells were treated with Roh123, 16,a nd the DNAs tain Hoechst 33342, and confocal images were acquired at three channels (Figure 4Fand imaged after 5min (Figure 4G and Figure S13 b) . Results show asignificant (ca. 13-fold) decrease in fluorescence signal only in cells within the light-exposed region while cells outside of it remains unaffected. Quantification of the averaged fluorescence intensities of cells within the irradiated area versus those outside of it, before and after light exposure, is shown in Figure 4H .
To demonstrate the general applicability of BODIPY photocages targeting,w es ynthesized an ER-targeted caged version of the protein synthesis inhibitor puromycin [15] (19, Figure S15 ). Compound 19 showed efficient light-dependent release of puromycin in vitro and in HeLa cells (Figure S15 B ) and colocalized efficiently with ER-tracker blue (r = 0.95, Figure S16 C). Following photoactivation of 19 in live cells (20 mm,5 45/305 nm, 42 mW cm À2 ), released puromycin could be detected specifically in the ER, unlike treatment with free puromycin that was detected throughout the cell (ER, cytoplasm, nucleus), as visualized by immunostaining (Figure S16 E) .
In summary,w ed eveloped as et of BODIPY photocages suitable for visible-light-mediated release of bioactive molecules in specific,p re-designated organelles.W eh ave established ap ost-synthetic procedure to straightforwardly introduce conjugatable functional groups onto BODIPY a-methyl in one synthetic step and without compromising their spectroscopic nor photoreaction properties.T his procedure represents au nique post-synthetic functionalization method applicable to BODIPYs at large,p roviding as imple and effective solution to the traditional challenge of BODIPY functionalization, usually requiring multi-step processes. [16] Thus,i tn ot only should provide access to conjugation of BODIPY photocages to other small-or macro-molecules but also uniquely represents asimple path to direct activation and further (bio-)conjugation of BODIPYs when used as fluorescent tags.T he developed procedure was applied to generate as et of organelle-targeted BODIPY photocages in ad ivergent manner.A ll organelle-targeted BODIPY photocages efficiently localized to their pre-designated sub-cellular compartments.Amitochondria-targeted BODIPY was demonstrated to release the protonophore DNP in live cells with exquisite spatio-temporal control, achieving am uch higher effect compared to non-targeted DNP.T hus,p hotocaging introduces spatio-temporal specificity to organelle targeting and leads to higher efficacy of the bioactive molecule,m ost probably owing to localized and abrupt release.F inally,w e expect that our approach could be extended to the selective delivery of aw ide range of bioactive molecules to diverse organelles in order to perturb and study their localized processes and functions.The use of BODIPY provides access to photoactivation with biologically benign visible light thus eliminating concerns of phototoxicity associated with traditional UV-excitable photocages and, potentially,opening the way to organelle-targeted light-mediated drug delivery.
